FRIDAY, Sept. 30, 2016 (HealthDay News) — Continuous glucose monitors are recommended for adults with type 1 diabetes, according to guidelines published online Sept. 2 in the Journal of Clinical Endocrinology and Metabolism.
Anne L. Peters, M.D., from the Keck School of Medicine in Los Angeles, and colleagues conducted a systematic literature review to develop evidence-based guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
The researchers found that continuous subcutaneous insulin infusion and continuous glucose monitoring have important roles in diabetes treatment. The existing studies support diabetes technology use for a variety of indications. The strongest recommendation was for individuals with type 1 diabetes who are able and willing to use the monitors. In addition, continuous glucose monitoring can be used on a short-term intermittent basis for individuals with type 2 diabetes. The use of insulin pumps was recommended over multiple insulin injections for individuals with type 1 diabetes who have not met their glycated hemoglobin goals. Pumps were also recommended for those with frequent hypoglycemia or glucose variability and for those with type 2 diabetes who are not meeting their glycemic goals.
“Scientific evidence supports the use of continuous glucose monitor technology in individuals with type 1 diabetes whose blood sugar is above the targeted level as well as those whose blood glucose is well managed,” Peters said in a statement.
Several authors disclosed financial ties to the pharmaceutical and medical device industries.
Copyright © 2016 HealthDay. All rights reserved.